Kidney cancer: open trials in Singapore

5 open trials have a site in Singapore. Registry data; only the trial team decides who can take part.

NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Trial Treatment · Phase 1/2 · Inhibrx Biosciences, Inc
Icon Cancer Centre Farrer Park, Singapore · Icon Cancer Centre - Mount Alvernia, Singapore · Curie Oncology, Singapore
Registry updated 2026-11-06
NCT07011719
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Trial Treatment · Phase 3 · Arcus Biosciences, Inc.
Singapore
Registry updated 2026-11-02
NCT07227402
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
National Cancer Centre Singapore (Site 2401), Singapore · National University Hospital (Site 2400), Singapore
Registry updated 2026-08-03
NCT03175224
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Trial Treatment · Phase 2 · Apollomics Inc.
National Cancer Centre Singapore, Singapore
Registry updated 2025-06-27
NCT05363657
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Research · Azienda Ospedaliero-Universitaria Careggi
NG Teng Fong General Hospital, Singapore
Registry updated 2022-05-06

This page is not medical advice. Talk to your doctor before contacting a trial.

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)